Found: 88
Select item for more details and to access through your institution.
"I feel it in my gut:" Epistemic Motivations, Political Beliefs, and Misperceptions of COVID-19 and the 2020 U.S. Presidential Election.
- Published in:
- Journal of Social & Political Psychology, 2022, v. 10, n. 2, p. 643, doi. 10.5964/jspp.7823
- By:
- Publication type:
- Article
Brain Imaging and Blood Biomarker Abnormalities in Children With Autosomal Dominant Alzheimer Disease.
- Published in:
- JAMA Dermatology, 2015, v. 151, n. 8, p. 912, doi. 10.1001/jamaneurol.2015.1099
- By:
- Publication type:
- Article
Alzheimer's Prevention Initiative: a plan to accelerate the evaluation of presymptomatic treatments.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Effects of the active amyloid beta immunotherapy CAD106 on PET measurements of amyloid plaque deposition in cognitively unimpaired APOE ε4 homozygotes.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, n. 3, p. 1839, doi. 10.1002/alz.13532
- By:
- Publication type:
- Article
Informed consent process experience in Alzheimer's Prevention Initiative (API) Autosomal Dominant Alzheimer's Disease Colombia trial.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.082483
- By:
- Publication type:
- Article
Contraception in Female Volunteer in Alzheimer's Prevention Initiative Autosomal‐dominant Alzheimer's disease Colombia Trial, a Phase II Clinical Trial to Test Safety and Efficacy of Crenezumab.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.082348
- By:
- Publication type:
- Article
Statistical innovations in the API ADAD Colombia trial: a randomized, double‐blind, placebo‐controlled, parallel‐group study in cognitively unimpaired PSEN1 E280A mutation carriers evaluating efficacy and safety of crenezumab.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 21, p. 1, doi. 10.1002/alz.070863
- By:
- Publication type:
- Article
How intention to join an Alzheimer's participant recruitment registry differs by race, ethnicity, sex, and family history: Results from a national survey of US adults.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 12, p. 5399, doi. 10.1002/alz.13126
- By:
- Publication type:
- Article
IC‐P‐010: COMPARING CEREBRAL WHITE MATTER, CEREBELLAR, AND PONTINE REFERENCE REGIONS TO CHARACTERIZE FLORBETAPIR PET MEASUREMENTS OF AMYLOID‐β BURDEN IN PSEN1 E280A MUTATION CARRIERS AND NONCARRIERS FROM THE COLOMBIAN AUTOSOMAL DOMINANT ALZHEIMER'S DISEASE KINDRED
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 14, p. P20, doi. 10.1016/j.jalz.2018.06.2074
- By:
- Publication type:
- Article
Recommendations to address key recruitment challenges of Alzheimer's disease clinical trials.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 2, p. 696, doi. 10.1002/alz.12737
- By:
- Publication type:
- Article
Why a clinical trial is as good as its outcome measure: A framework for the selection and use of cognitive outcome measures for clinical trials of Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 2, p. 708, doi. 10.1002/alz.12773
- By:
- Publication type:
- Article
API ADAD Colombia Trial initial findings: a randomized, double‐blind, placebo‐controlled, parallel‐ group study in cognitively unimpaired PSEN1 E280A mutation carriers evaluating efficacy and safety of crenezumab.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 10, p. 1, doi. 10.1002/alz.069724
- By:
- Publication type:
- Article
Clinical Profiles of Persons Who Progress to Cognitive Impairment in the Alzheimer's Prevention Initiative (API) ADAD Colombia Trial.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 7, p. 1, doi. 10.1002/alz.069107
- By:
- Publication type:
- Article
Effect of APOE4 on Plasma Phospho‐tau 217 and Neurofilament Light in the PSEN1 E280A Autosomal Dominant Alzheimer's Disease Colombian Kindred.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 6, p. 1, doi. 10.1002/alz.069090
- By:
- Publication type:
- Article
Reproductive health data and its relationship to baseline brain imaging and cognitive measurements in cognitively unimpaired female PSEN1 E280A mutation carriers and non‐carriers from the API ADAD Trial.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 5, p. 1, doi. 10.1002/alz.062000
- By:
- Publication type:
- Article
Sex differences in cognitive resilience in preclinical autosomal‐dominant Alzheimer's disease carriers and non‐carriers: Baseline findings from the API ADAD Colombia Trial.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 11, p. 2272, doi. 10.1002/alz.12552
- By:
- Publication type:
- Article
Psychological status in the participants of the API ADAD Colombia trial assisted by a comprehensive mental health program during COVID 19 pandemic.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.057396
- By:
- Publication type:
- Article
What words and concepts do people enrolled in research registries use to describe them?
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.056141
- By:
- Publication type:
- Article
Mixed methods used in the refinement of an Alzheimer's study registry to optimize recruitment of Latinx and Black individuals.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.054137
- By:
- Publication type:
- Article
API generation program: Active immunotherapy CAD106 slows amyloid deposition in cognitively unimpaired APOE4 homozygotes.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.051287
- By:
- Publication type:
- Article
Depression and anxiety disorder along life in familial Alzheimer's disease in the API ADAD Colombia trial: Neuropsychiatry and behavioral neurology/Assessment/Measurement of neuropsychiatric/Behavioral and psychological symptoms.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 6, p. 1, doi. 10.1002/alz.041314
- By:
- Publication type:
- Article
Screening characteristics of PSEN1 E280A mutation carriers and non‐carriers in the API Autosomal Dominant Alzheimer's Disease Colombia Trial: Neuropsychiatry and behavioral neurology/presymptomatic disease/prodromal disease/prodromal states.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 6, p. 1, doi. 10.1002/alz.040336
- By:
- Publication type:
- Article
Comparison of digital platforms for participant recruitment in dementia research: Lessons and future directions from a global collaborative: Epidemiology / Innovative methods in epidemiology (i.e., assessment methods, design, recruitment strategies, statistical methods, etc.)
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.046401
- By:
- Publication type:
- Article
The Alzheimer's Prevention Registry: Accelerating recruitment and enrollment into Alzheimer's‐focused studies: Epidemiology / Innovative methods in epidemiology (i.e., assessment methods, design, recruitment strategies, statistical methods, etc.).
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.043931
- By:
- Publication type:
- Article
The Alzheimer's Prevention Registry: Success metrics and lessons learned in registry member retention through online engagement campaigns: Epidemiology / Innovative methods in epidemiology (i.e., assessment methods, design, recruitment strategies, statistical methods, etc.)
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.043531
- By:
- Publication type:
- Article
Real‐world site experiences with a recruitment‐related registry: An exploration of Alzheimer's disease prevention research recruitment: Prevention (nonpharmacological) / Other.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.043433
- By:
- Publication type:
- Article
Success of referring participants to the Generation program and lessons learned for future enrollment into Alzheimer's disease prevention trials: Human: Improving clinical trial methodology.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.043112
- By:
- Publication type:
- Article
Depression and anxiety disorder along life in familial Alzheimer's disease in the API ADAD Colombia trial: Neuropsychiatry and behavioral neurology/Assessment/Measurement of neuropsychiatric/Behavioral and psychological symptoms.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.041314
- By:
- Publication type:
- Article
Sex differences in neurodegeneration and memory performance in preclinical autosomal dominant Alzheimer's disease: Baseline findings from the API ADAD trial: Intersections of sex/gender and race/ethnicity in cognitive aging and Alzheimer's disease trajectories
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.041225
- By:
- Publication type:
- Article
The API Generation program: Umibecestat treatment and discontinuation effects on hippocampal and whole brain volumes in the overall population and amyloid‐negative APOE4 homozygotes: Alzheimer's Prevention Initiative (API) Generation program: Baseline characteristics and umibecestat results during treatment and follow‐up
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.041142
- By:
- Publication type:
- Article
Umibecestat in the API Generation program: Worsening in RBANS and/or CDR on treatment reverses after wash‐out: Alzheimer's Prevention Initiative (API) Generation program: Baseline characteristics and umibecestat results during treatment and follow‐up
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.041140
- By:
- Publication type:
- Article
The Generation program: Baseline characteristics of cognitively unimpaired APOE4 carriers recruited for Generation study 1 and Generation study 2: Alzheimer's Prevention Initiative (API) Generation program: Baseline characteristics and umibecestat results during treatment and follow‐up
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.041139
- By:
- Publication type:
- Article
Screening characteristics of PSEN1 E280A mutation carriers and non‐carriers in the API Autosomal Dominant Alzheimer's Disease Colombia Trial: Neuropsychiatry and behavioral neurology/presymptomatic disease/prodromal disease/prodromal states.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.040336
- By:
- Publication type:
- Article
The Alzheimer's prevention initiative Generation program: A global perspective on best practices for site support and engagement to accelerate participant recruitment: Clinical trial design and implementation.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.039186
- By:
- Publication type:
- Article
Baseline demographic, clinical, and cognitive characteristics of the Alzheimer's Prevention Initiative (API) Autosomal‐Dominant Alzheimer's Disease Colombia Trial.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 7, p. 1023, doi. 10.1002/alz.12109
- By:
- Publication type:
- Article
P4‐458: FACEBOOK AS A RESOURCE FOR HISPANIC/LATINO RECRUITMENT: A PILOT PROGRAM OF THE ALZHEIMER'S PREVENTION REGISTRY.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P1479, doi. 10.1016/j.jalz.2019.06.4130
- By:
- Publication type:
- Article
F4‐04‐04: ASSOCIATION BETWEEN CEREBRAL AMYLOIDOSIS AND WORSE COGNITIVE PERFORMANCE IN PRECLINICAL AUTOSOMAL DOMINANT ALZHEIMER'S DISEASE: BASELINE FINDINGS FROM THE API COLOMBIA AUTOSOMAL DOMINANT AD TRIAL.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P1224, doi. 10.1016/j.jalz.2019.06.4728
- By:
- Publication type:
- Article
F4‐04‐03: RELATIONSHIPS BETWEEN BASELINE BRAIN IMAGING BIOMARKER MEASUREMENTS AND AGE IN THE API AUTOSOMAL DOMINANT ALZHEIMER'S DISEASE COLOMBIA TRIAL.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P1223, doi. 10.1016/j.jalz.2019.06.4727
- By:
- Publication type:
- Article
F4‐04‐02: AGE‐RELATED CHANGES IN BASELINE COGNITIVE MEASURES IN UNIMPAIRED PSEN1 E280A MUTATION CARRIERS AND NON‐CARRIERS IN THE API AUTOSOMAL DOMINANT ALZHEIMER'S DISEASE COLOMBIA TRIAL.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P1223, doi. 10.1016/j.jalz.2019.06.4726
- By:
- Publication type:
- Article
F4‐04‐01: TRIAL DESIGN, DATA SHARING RISK MITIGATION, AND BASELINE CLINICAL AND COGNITIVE DATA FROM THE API AUTOSOMAL DOMINANT ALZHEIMER'S DISEASE COLOMBIA TRIAL.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P1222, doi. 10.1016/j.jalz.2019.06.4725
- By:
- Publication type:
- Article
P3‐033: GENEMATCH: A NOVEL RECRUITMENT REGISTRY OF APOE CHARACTERIZED ADULTS TO ACCELERATE RECRUITMENT AND ENROLLMENT INTO ALZHEIMER'S PREVENTION STUDIES.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P938, doi. 10.1016/j.jalz.2019.06.3059
- By:
- Publication type:
- Article
P3‐010: THE LARGEST GLOBAL SURVEY TO DATE OF ADULT PERCEPTIONS OF ALZHEIMER'S DISEASE AND CLINICAL TRIAL PARTICIPATION.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P928, doi. 10.1016/j.jalz.2019.06.3036
- By:
- Publication type:
- Article
F2‐03‐04: ASSESSING CLINICAL MEANINGFULNESS OF OUTCOMES IN THE ALZHEIMER'S PREVENTION INITIATIVE GENERATION PROGRAM.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P520, doi. 10.1016/j.jalz.2019.06.4427
- By:
- Publication type:
- Article
GeneMatch: A novel recruitment registry using at‐home APOE genotyping to enhance referrals to Alzheimer's prevention studies.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, n. 4, p. 515, doi. 10.1016/j.jalz.2018.12.007
- By:
- Publication type:
- Article
P4‐209: A PUBLIC RESOURCE OF BASELINE DATA FROM THE API AUTOSOMAL DOMINANT ALZHEIMER'S DISEASE COLOMBIA TRIAL.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P1521, doi. 10.1016/j.jalz.2018.07.030
- By:
- Publication type:
- Article
P3‐024: THE ALZHEIMER'S PREVENTION REGISTRY'S GENEMATCH PROGRAM: UPDATE ON PROGRESS AND LESSONS LEARNED IN HELPING TO ACCELERATE ENROLLMENT INTO ALZHEIMER'S PREVENTION STUDIES.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P1073, doi. 10.1016/j.jalz.2018.06.1379
- By:
- Publication type:
- Article
P3‐022: THE ALZHEIMER'S PREVENTION INITIATIVE (API) PROGRAM: DESIGN AND DEVELOPMENT OF AN APOE COUNSELING AND DISCLOSURE PROGRAM.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P1072, doi. 10.1016/j.jalz.2018.06.1377
- By:
- Publication type:
- Article
P2‐071: COMPARING CEREBRAL WHITE MATTER, CEREBELLAR, AND PONTINE REFERENCE REGIONS TO CHARACTERIZE FLORBETAPIR PET MEASUREMENTS OF AMYLOID‐β BURDEN IN PSEN1 E280A MUTATION CARRIERS AND NONCARRIERS FROM THE COLOMBIAN AUTOSOMAL DOMINANT ALZHEIMER'S DISEASE KINDRED
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P694, doi. 10.1016/j.jalz.2018.06.756
- By:
- Publication type:
- Article
IC‐P‐010: COMPARING CEREBRAL WHITE MATTER, CEREBELLAR, AND PONTINE REFERENCE REGIONS TO CHARACTERIZE FLORBETAPIR PET MEASUREMENTS OF AMYLOID‐β BURDEN IN PSEN1 E280A MUTATION CARRIERS AND NONCARRIERS FROM THE COLOMBIAN AUTOSOMAL DOMINANT ALZHEIMER'S DISEASE KINDRED
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P20, doi. 10.1016/j.jalz.2018.06.2074
- By:
- Publication type:
- Article
The Alzheimer's Prevention Initiative Composite Cognitive Test: a practical measure for tracking cognitive decline in preclinical Alzheimer's disease.
- Published in:
- Alzheimer's Research & Therapy, 2020, v. 12, n. 1, p. 1, doi. 10.1186/s13195-020-00633-2
- By:
- Publication type:
- Article